| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
A case of polycyclic Sweet’s syndrome arising from azacitidine injection sites in myelodysplasia
|
Berry, William A.
|
|
|
99 |
1 |
p. 201-202
|
article
|
| 2 |
A novel SNP rs11759328 on Rho GTPase-activating protein 18 gene is associated with the expression of Hb F in hemoglobin E-related disorders
|
Jomoui, Wittaya
|
|
|
99 |
1 |
p. 23-29
|
article
|
| 3 |
Atypical mycobacteria diagnosed by bone marrow biopsy in an HIV-positive patient
|
Zanelli, Magda
|
|
|
99 |
1 |
p. 183-184
|
article
|
| 4 |
Bilateral vision loss in Waldenstrom’s macroglobulinemia
|
Vasileiou, Vasiliki
|
|
|
99 |
1 |
p. 193-194
|
article
|
| 5 |
Clinical impact of the CONUT score in patients with multiple myeloma
|
Okamoto, Sho
|
|
|
99 |
1 |
p. 113-119
|
article
|
| 6 |
Congenital dyserythropoietic anemia type I mimicking myelodysplasia syndrome with a novel CDAN1 mutation
|
Lv, Xueyan
|
|
|
99 |
1 |
p. 197-199
|
article
|
| 7 |
Correction to: Clinical outcomes in patients with diffuse large B cell lymphoma with a partial response to first-line R-CHOP chemotherapy: prognostic value of secondary International Prognostic Index scores and Deauville scores
|
Lee, Hyewon
|
|
|
99 |
1 |
p. 213
|
article
|
| 8 |
Correction to: The prognostic value of serum erythropoietin in patients with lower-risk myelodysplastic syndromes: a review of the literature and expert opinion
|
Park, Sophie
|
|
|
99 |
1 |
p. 21
|
article
|
| 9 |
Daratumumab-associated hemophagocytic lymphohistiocytosis
|
Woods, Ashley
|
|
|
99 |
1 |
p. 181-182
|
article
|
| 10 |
Erythroferrone, the new iron regulator: evaluation of its levels in Egyptian patients with beta thalassemia
|
El-Gamal, Rasha Abd El-Rahman
|
|
|
99 |
1 |
p. 31-39
|
article
|
| 11 |
Evaluation of thrombotic events in patients with immune thrombocytopenia
|
Ito, Shoko
|
|
|
99 |
1 |
p. 49-55
|
article
|
| 12 |
Iron deficiency: an independent prognostic marker in heart failure
|
Sahu, Kamal Kant
|
|
|
99 |
1 |
p. 211-212
|
article
|
| 13 |
Magnetic resonance imaging and 18F-fluorodeoxyglucose positron emission tomography/computed tomography findings in neurolymphomatosis: an uncommon presentation of diffuse large B cell lymphoma
|
Switlyk, Marta D.
|
|
|
99 |
1 |
p. 203-205
|
article
|
| 14 |
MEF2D-rearranged acute lymphoblastic leukemia resembles Burkitt lymphoma/leukemia
|
Sun, Jiewen
|
|
|
99 |
1 |
p. 185-188
|
article
|
| 15 |
Primary central nervous system lymphoma in China: a single-center retrospective analysis of 167 cases
|
Yuan, Xiang-Gui
|
|
|
99 |
1 |
p. 93-104
|
article
|
| 16 |
Prognostic significance of FDG-PET/CT in determining upfront autologous stem cell transplantation for the treatment of peripheral T cell lymphomas
|
Ahn, Seo-Yeon
|
|
|
99 |
1 |
p. 83-91
|
article
|
| 17 |
Prognostic significance of hyperfibrinogenemia in patients with lower-risk myelodysplastic syndromes
|
Ogura, Shinji
|
|
|
99 |
1 |
p. 189-191
|
article
|
| 18 |
Randomized controlled trial of twice-daily versus alternate-day oral iron therapy in the treatment of iron-deficiency anemia
|
Kaundal, Rahul
|
|
|
99 |
1 |
p. 57-63
|
article
|
| 19 |
Reduced risk of chronic GVHD by low-dose rATG in adult matched sibling donor peripheral blood stem cell transplantation for hematologic malignancies
|
Dou, Liping
|
|
|
99 |
1 |
p. 167-179
|
article
|
| 20 |
R-GEM-Lenalidomide versus R-GEM-P as second-line treatment of diffuse large B-cell lymphoma: results of the UK NRCI phase II randomised LEGEND trial
|
Kühnl, Andrea
|
|
|
99 |
1 |
p. 105-112
|
article
|
| 21 |
R-GEM-Lenalidomide versus R-GEM-P as second-line treatment of diffuse large B-cell lymphoma: results of the UK NRCI phase II randomised LEGEND trial
|
Kühnl, Andrea
|
|
|
99 |
1 |
p. 105-112
|
article
|
| 22 |
Sequential therapy of four cycles of bortezomib, melphalan, and prednisolone followed by continuous lenalidomide and dexamethasone for transplant-ineligible newly diagnosed multiple myeloma
|
Isa, Reiko
|
|
|
99 |
1 |
p. 137-145
|
article
|
| 23 |
Sequential therapy of four cycles of bortezomib, melphalan, and prednisolone followed by continuous lenalidomide and dexamethasone for transplant-ineligible newly diagnosed multiple myeloma
|
Isa, Reiko
|
|
|
99 |
1 |
p. 137-145
|
article
|
| 24 |
Systematic review on the value of end-of-treatment FDG-PET in improving overall survival of lymphoma patients
|
Adams, Hugo J.A.
|
|
|
99 |
1 |
p. 1-5
|
article
|
| 25 |
Systemic mastocytosis associated with acute myeloid leukemia
|
Nogueira, Frederico Lisboa
|
|
|
99 |
1 |
p. 195-196
|
article
|
| 26 |
The incidence of thromboembolism for lenalidomide versus thalidomide in older patients with newly diagnosed multiple myeloma
|
Li, Ang
|
|
|
99 |
1 |
p. 121-126
|
article
|
| 27 |
The increased neopterin content in turkish pediatric patients with sickle cell anemia
|
Sabuncuoğlu, Suna
|
|
|
99 |
1 |
p. 41-47
|
article
|
| 28 |
The predictive value of minimal residual disease when facing the inconsistent results detected by real-time quantitative PCR and flow cytometry in NPM1-mutated acute myeloid leukemia
|
Gao, Meng-Ge
|
|
|
99 |
1 |
p. 73-82
|
article
|
| 29 |
The prognostic value of serum erythropoietin in patients with lower-risk myelodysplastic syndromes: a review of the literature and expert opinion
|
Park, Sophie
|
|
|
99 |
1 |
p. 7-19
|
article
|
| 30 |
Tracing the decision-making process for myelofibrosis: diagnosis, stratification, and management of ruxolitinib therapy in real-word practice
|
Breccia, Massimo
|
|
|
99 |
1 |
p. 65-72
|
article
|
| 31 |
Treatment of primary plasma cell leukemia with high doses of cyclophosphamide, bortezomib, and dexamethasone followed by double autologous HSCT
|
Pagano, Livio
|
|
|
99 |
1 |
p. 207-209
|
article
|
| 32 |
Unmanipulated haploidentical hematopoietic stem cell transplantation using very low-dose antithymocyte globulin and methylprednisolone in adults with relapsed/refractory acute leukemia
|
Konishi, Tatsuya
|
|
|
99 |
1 |
p. 147-155
|
article
|
| 33 |
Visual and volumetric parameters by 18F-FDG-PET/CT: a head to head comparison for the prediction of outcome in patients with multiple myeloma
|
Fonti, Rosa
|
|
|
99 |
1 |
p. 127-135
|
article
|
| 34 |
When an HLA identical donor is not available in adults with hematological neoplasms: single-center comparison of single-unit cord blood transplantation and haploidentical-related PBSC transplantation with PTCy using a standardized conditioning platform (thiotepa-busulfan-fludarabine)
|
Esquirol, Albert
|
|
|
99 |
1 |
p. 157-165
|
article
|
Journal description